HPGD and colonic neoplasm: The expression and activity of 15-PGDH is repressed in colorectal cancer and Apcmin mouse adenomas, leading to a decrease in PGE2 catabolism, local tissue accumulation of PGE2 and resistance to Celecoxib chemoprevention in colon tumors [11], [13].